Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Efficacy of intravenous Ig therapy in juvenile dermatomyositis.

Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM.

Ann Rheum Dis. 2011 Dec;70(12):2089-94. doi: 10.1136/ard.2011.153718. Epub 2011 Oct 6.

PMID:
21978999
2.

Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.

Al-Mayouf SM, Laxer RM, Schneider R, Silverman ED, Feldman BM.

J Rheumatol. 2000 Oct;27(10):2498-503.

PMID:
11036850
3.

Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.

Cherin P, Piette JC, Wechsler B, Bletry O, Ziza JM, Laraki R, Godeau P, Herson S.

J Rheumatol. 1994 Jun;21(6):1092-7.

PMID:
7932419
4.

[Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].

Breems DA, de Haas PW, Visscher F, Sabbe LJ, Busch HF, van Doorn PA.

Ned Tijdschr Geneeskd. 1993 Sep 25;137(39):1979-82. Dutch.

PMID:
8413708
5.

Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.

Cherin P, Herson S, Wechsler B, Piette JC, Bletry O, Coutellier A, Ziza JM, Godeau P.

Am J Med. 1991 Aug;91(2):162-8.

PMID:
1714235
6.

Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.

Wang DX, Shu XM, Tian XL, Chen F, Zu N, Ma L, Wang GC.

Clin Rheumatol. 2012 May;31(5):801-6. doi: 10.1007/s10067-012-1940-5. Epub 2012 Jan 26. Review.

PMID:
22274797
7.

Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.

Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.

Arch Dis Child. 2008 Feb;93(2):142-6. Epub 2007 Oct 25.

PMID:
17962370
8.

Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.

Levy DM, Bingham CA, Kahn PJ, Eichenfield AH, Imundo LF.

J Pediatr. 2010 Feb;156(2):302-7. doi: 10.1016/j.jpeds.2009.09.008. Epub 2009 Oct 28.

9.

Juvenile dermatomyositis: recognition and treatment.

Reed AM, Lopez M.

Paediatr Drugs. 2002;4(5):315-21. Review.

PMID:
11994036
10.

Long-term, high-dose intravenous immunoglobulin therapy in a patient with banker-type juvenile dermatomyositis.

Imataka G, Arisaka O.

Cell Biochem Biophys. 2014 Jul;69(3):747-8. doi: 10.1007/s12013-014-9833-7.

11.

Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group.

Giannini EH, Lovell DJ, Silverman ED, Sundel RP, Tague BL, Ruperto N.

J Rheumatol. 1996 May;23(5):919-24.

PMID:
8724309
12.

Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.

Marie I, Menard JF, Hatron PY, Hachulla E, Mouthon L, Tiev K, Ducrotte P, Cherin P.

Arthritis Care Res (Hoboken). 2010 Dec;62(12):1748-55. doi: 10.1002/acr.20325.

13.

Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.

Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S.

Arthritis Rheum. 2002 Feb;46(2):467-74.

PMID:
11840450
14.

Intravenous immunoglobulin therapy for refractory myositis.

Moriguchi M, Suzuki T, Tateishi M, Hara M, Kashiwazaki S.

Intern Med. 1996 Aug;35(8):663-7.

15.
16.
17.

Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin.

Vedanarayanan V, Subramony SH, Ray LI, Evans OB.

Pediatr Neurol. 1995 Nov;13(4):336-9.

PMID:
8771171
18.

Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use.

Santiago RA, Silva CA, Caparbo VF, Sallum AM, Pereira RM.

Scand J Rheumatol. 2008 Jan-Feb;37(1):40-7. doi: 10.1080/03009740701687226.

PMID:
18189194
19.

Intravenous immunoglobulin therapy in juvenile dermatomyositis.

Tsai MJ, Lai CC, Lin SC, Chiang BL, Chou CC, Hsieh KH.

Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1997 Mar-Apr;38(2):111-5.

PMID:
9151463
20.

Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.

Suzuki Y, Hayakawa H, Miwa S, Shirai M, Fujii M, Gemma H, Suda T, Chida K.

Lung. 2009 May-Jun;187(3):201-6. doi: 10.1007/s00408-009-9146-6. Epub 2009 Apr 22.

PMID:
19387736

Supplemental Content

Support Center